The antidiabetic activity of nigella sativa and propolis on streptozotocin-induced diabetes and diabetic nephropathy in male rats

Evidence-based Complementary and Alternative Medicine

Volumn 2017, Issue , 2017, Pages

  El Rabey, Haddad A ^a,b   Al Seeni, Madeha N ^a   Bakhashwain, Amal S ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF SADAT CITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ALBUMIN; CAROTENOID; CATALASE; CREATININE; FLAVONOID; GLUCOSE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 6; LIPID PEROXIDE; MALONALDEHYDE; METHANOL; NIGELLA SATIVA EXTRACT; POTASSIUM; PROPOLIS; SODIUM; STREPTOZOCIN; SUPEROXIDE DISMUTASE; UREA; URIC ACID;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; APITHERAPY; ARTICLE; BIOCHEMICAL ANALYSIS; BLACK CUMIN; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIABETES CONTROL; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ETHNOPHARMACOLOGY; EXPERIMENTAL DIABETIC NEPHROPATHY; FLUID INTAKE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY FUNCTION; KIDNEY TISSUE; LIPID PEROXIDATION; MALE; NONHUMAN; PANCREAS TISSUE; PHYTOCHEMISTRY; PLANT SEED; POTASSIUM BLOOD LEVEL; PROTEIN BLOOD LEVEL; RAT; RENAL PROTECTION; SODIUM BLOOD LEVEL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 85014483218     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2017/5439645     Document Type: Article

References (67)

1. I. Vlad and A. R. Popa, "Epidemiology of diabetes mellitus: a current review," Romanian Journal of Diabetes, Nutrition and Metabolic Diseases, vol. 19, no. 4, pp. 433-440, 2012.
2. A. H. Al-Assaf, "Antihyperglycemic and antioxidant effect of ginger extract on streptozotocin-diabetic rats," Pakistan Journal of Nutrition, vol. 11, no. 12, pp. 1107-1112, 2012.
3. A. L. Al-Malki and H. A. El Rabey, "The antidiabetic effect of low doses of moringa oleifera lam. Seeds on streptozotocin induced diabetes and diabetic nephropathy in male rats," BioMed Research International, vol. 2015, Article ID 381040, 13 pages, 2015.
4. A. L. Al-Malki, "Oat attenuation of hyperglycemia-induced retinal oxidative stress and NF-κB activation in streptozotocininduced diabetic rats," Evidence-based Complementary and AlternativeMedicine, vol. 2013, Article ID 983923, 8 pages, 2013.
5. M. Van Eupen, M. Schram, H. Colhoun, J. Scheijen, C. Stehouwer, and C. Schalkwijk, "Plasma levels of advanced glycation end products are associated with type 1 diabetes and coronary artery calcification," Cardiovascular Diabetology, vol. 12, pp. 149-157, 2013.
6. N. Khandouzi, F. Shidfar, A. Rajab, T. Rahideh, P. Hosseini, and M. M. Taheri, "The effects of ginger on fasting blood sugar, hemoglobin A1c, apolipoprotein B, apolipoprotein AI and malondialdehyde in type 2 diabetic patients," Iranian Journal of Pharmaceutical Research, vol. 14, no. 1, pp. 131-140, 2015.
7. A. Al-Logmani and T. Zari, "Long-term effects of Nigella sativa L. oil on some physiological parameters in normal and streptozotocin-induced diabetic rats," Journal of Diabetes Mellitus, vol. 1, no. 3, pp. 46-53, 2011.
8. M. Kanter, I. Meral, Z. Yener, H. Ozbek, and H. Demir, "Partial regeneration/proliferation of the β-cells in the Islets of Langerhans by Nigella sativa L. in streptozotocin-induced diabetic rats,"The Tohoku Journal of ExperimentalMedicine, vol. 201, no. 4, pp. 213-219, 2003.
9. A. Bamosa, "A review on the hypoglycemic effect of Nigella sativa and thymoquinone," Saudi Journal of Medicine Medical Sciences, vol. 3, no. 1, pp. 2-7, 2015.
10. M. A. Randhawa and M. S. Alghamdi, "Anticancer activity of Nigella sativa (black seed)-a review," The American Journal of Chinese Medicine, vol. 39, no. 6, pp. 1075-1091, 2011.
11. C.-C. Toma, N.-K. Olah, L. Vlase, C. Mogosan, and A. Mocan, "Comparative studies on polyphenolic composition, antioxidant and diuretic effects of nigella sativa L. (black cumin) and nigella damascena L. (Lady-in-a-Mist) seeds,"Molecules, vol. 20, no. 6, pp. 9560-9574, 2015.
12. N. Paulino, S. R. L. Abreu, Y. Uto et al., "Anti-inflammatory effects of a bioavailable compound, Artepillin C, in Brazilian propolis," European Journal of Pharmacology, vol. 587, no. 1-3, pp. 296-301, 2008.
13. E. Gregoris and R. Stevanato, "Correlations between polyphenolic composition and antioxidant activity of Venetian propolis," FoodandChemical Toxicology, vol. 48,no. 1, pp. 76-82, 2010.
14. B. Kouidhi, T. Zmantar, and A. Bakhrouf, "Anti-cariogenic and anti-biofilms activity of Tunisian propolis extract and its potential protective effect against cancer cells proliferation," Anaerobe, vol. 16, no. 6, pp. 566-571, 2010.
15. L.-J. Kang, H. B. Lee, H.-J. Bae, and S.-G. Lee, "Antidiabetic effect of propolis: reduction of expression of glucose-6-phosphatase through inhibition of Y279 and Y216 autophosphorylation of GSK-3α/β in HepG2 cells," Phytotherapy Research, vol. 24, no. 10, pp. 1554-1561, 2010.
16. P. Schnitzler, A. Neuner, S. Nolkemper et al., "Antiviral activity and mode of action of propolis extracts and selected compounds," Phytotherapy Research, vol. 24, no. 1, pp. 20-28, 2010.
17. D. Skaba, T. Morawiec, M. Tanasiewicz et al., "Influence of the toothpaste with brazilian ethanol extract propolis on the oral cavity health," Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 215391, 12 pages, 2013.
18. E. Shruthi and B. S. Suma, "Health fromthe hive: potential uses of propolis in general health," International Journal of Clinical Medicine, vol. 3, no. 3, pp. 159-162, 2012.
19. M. Dubois, K. A. Gilles, J. K. Hamilton, P. A. Rebers, and F. Smith, "Colorimetric method for determination of sugars and related substances," Analytical Chemistry, vol. 28,no. 3, pp. 350-356, 1956.
20. E.Adebayo,O. Ishola, O. Taiwo, O. Majolagbe, and B.Adekeye, "Evaluations of the methanol extract of Ficus exasperata stem bark, leaf and root for phytochemical analysis and antimicrobial," African Journal of Plant Science, vol. 3, no. 12, pp. 283-287, 2009.
21. J. Zhishen,T.Mengcheng, andW. Jianming, "The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals," Food Chemistry, vol. 64, no. 4, pp. 555-559, 1999.
22. D. Barham and P. Trinder, "An improved colour reagent for the determination of blood glucose by the oxidase system," The Analyst, vol. 97, no. 1151, p. 142, 1972.
23. H. Ohkawa, N. Ohishi, and K. Yagi, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction," Analytical Biochemistry, vol. 95, no. 2, pp. 351-358, 1979.
24. M. Nishikimi, N. Appaji Rao, and K. Yagi, "The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen," Biochemical and Biophysical Research Communications, vol. 46, no. 2, pp. 849-854, 1972.
25. H.Aebi, "Catalase in vitro,"Methods in Enzymology, vol. 105, pp. 121-126, 1984.
26. W. Habig, M. Pabst, andW. Jakoby, "Glutathione S-transferase: the first enzymatic step in mercapturic acid formation," The Journal of Biological Chemistry, vol. 249, no. 22, pp. 7130-7139, 1974.
27. M. Hibi, K. Nakajima, and T. Hirano, "IL-6 cytokine family and signal transduction: a model of the cytokine system," Journal of Molecular Medicine, vol. 74, no. 1, pp. 1-12, 1996.
28. J. L. Fahey and E. M. Mckelvey, "Quantitative determination of serum immunoglobulins in antibody-agar," The Journal of Immunology, vol. 94, pp. 84-90, 1965.
29. G. Berne, "Detection of total IgG," Clinical Chemistry, vol. 200, pp. 61-89, 1974.
30. L. J. Seigel,M. E. Harper,F.Wong-Staal, R. C. Gallo,W. G. Nash, and S. J. OBrien, "Gene for T-cell growth factor: location on human chromosome 4q and feline chromosome B1," Science, vol. 223, no. 4632, pp. 175-178, 1984.
31. J. K. Fawcett and J. E. Scott, "A rapid and precisemethod for the determination of urea," Journal of Clinical Pathology, vol. 13, pp. 156-159, 1960.
32. H. Bartels, M. Bohmer, and C. Heierli, "Serum creatinine determination without protein precipitation," Clinica Chimica Acta, vol. 37, pp. 193-197, 1972.
33. P. Fossati, L. Prencipe, and G. Berti, "Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine," Clinical Chemistry, vol. 26, no. 2, pp. 227-231, 1980.
34. A. A. R. Sayed, "Ferulsinaic acid modulates SOD, GSH, and antioxidant enzymes in diabetic kidney," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 580104, 9 pages, 2012.
35. P. Trinder, "A rapid method for the determination of sodium in serum," The Analyst, vol. 76, no. 907, pp. 596-599, 1951.
36. A. Terri and P. Sesin, "Determination of serum potassium by using sodium tetraphenylboro method," American Journal of Clinical Pathology, vol. 29, no. 1, pp. 86-90, 1958.
37. B. Davies and T. Morris, "Physiological parameters in laboratory animals and humans," Pharmaceutical Research, vol. 10, no. 7, pp. 1093-1095, 1993.
38. R. Drury, E.Wallington, and R. Cancerson, Carletons Histological Technique,OxfordUniversityPress,Oxford,UK, 4thedition, 1976.
39. SAS (Statistical Analysis System), SAS Users Guide: Statistics, Version 5, SAS Institute, Cary, NC,USA, 1986.
40. T. Szkudelski, "The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas," Physiological Research, vol. 50, no. 6, pp. 537-546, 2001.
41. C. O. Eleazu, K. C. Eleazu, S. Chukwuma, and U. N. Essien, "Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans," Journal of Diabetes andMetabolic Disorders, vol. 12, no. 1, article 60, 2013.
42. N. E. Abdelmeguid, R. Fakhoury, S. M. Kamal, and R. J. Al Wafai, "Effects of Nigella sativa and thymoquinone on biochemical and subcellular changes in pancreatic β-cells of streptozotocin-induced diabetic rats," Journal of Diabetes, vol. 2, no. 4, pp. 256-266, 2010.
43. A.Abdulbasit,M.Oladayo, F.Olamide,O.Olasile, I. Babatunde, and B. Gbolahan, "Effect ofNigerian propolis on glycemia, lipid profile, and oxidative stressmarkers in alloxan-induced diabetic rats," Pharmacologyonline, vol. 2, pp. 149-158, 2013.
44. D. Gomathi, M. Kalaiselvi, G. Ravikumar, K. Devaki, and C. Uma, "Evaluation of antioxidants in the kidney of streptozotocin induced diabetic rats," Indian Journal of Clinical Biochemistry, vol. 29, no. 2, pp. 221-226, 2014.
45. P. Suryanarayana, A. Satyanarayana, N. Balakrishna, P. U. Kumar, and G. Bhanuprakash Reddy, "Effect of turmeric and curcumin on oxidative stress and antioxidant enzymes in streptozotocin-induced diabetic rat," Medical Science Monitor, vol. 13, no. 12, pp. BR286-BR292, 2007.
46. M. G.Miguel, S. Nunes, S. A. Dandlen, A. M. Cavaco, andM. D. Antunes, "Phenols, flavonoids and antioxidant activity of aqueous and methanolic extracts of propolis (Apis mellifera L.) from Algarve, South Portugal," Food Science and Technology, vol. 34, no. 1, pp. 16-23, 2014.
47. Y. J. Chen, M. L. Sheu, K. S. Tsai, R. S. Yang, and S. H. Liu, "Advanced glycation end products induce peroxisome proliferator-activated receptor γ down-regulation-related inflammatory signals in human chondrocytes via toll-like receptor-4 and receptor for advanced glycation end products," PLoS ONE, vol. 8, no. 6, Article ID e66611, 2013.
48. S. Bashandy, G. Jaleel, H. Abdallah, and S. Harraz, "Therapeutic implications of thymoquinone in the management of diabetes mellitus and its complications," American Journal of Phytomedicine and Clinical Therapeutics, vol. 3, no. 3, pp. 287-301, 2015.
49. A. A. Al Ghamdi, G. Badr, W. N. Hozzein et al., "Oral supplementation of diabetic mice with propolis restores the proliferation capacity and chemotaxis of B and T lymphocytes towards CCL21 and CXCL12 bymodulating the lipid profile, the pro-inflammatory cytokine levels and oxidative stress," BMC Immunology, vol. 16, no. 1, article no. 54, 2015.
50. A.Gonzalez-Quintela, R.Alende, F.Gude et al., "Serumlevels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities," Clinical and Experimental Immunology, vol. 151, no. 1, pp. 42-50, 2008.
51. S. Scheller, G. Gazda, G. Pietsz et al., "The ability of ethanol extract of propolis to stimulate plaque formation in immunized mouse spleen cells," Pharmacological ResearchCommunications, vol. 20, no. 4, pp. 323-328, 1988.
52. K. M. Fararh, Y. Atoji, Y. Shimizu, T. Shiina, H. Nikami, and T. Takewaki, "Mechanisms of the hypoglycaemic and immunopotentiating effects of Nigella sativa L. oil in streptozotocininduced diabetic hamsters," Research in Veterinary Science, vol. 77, no. 2, pp. 123-129, 2004.
53. P. Vigneri, F. Frasca, L. Sciacca, G. Pandini, and R. Vigneri, "Diabetes and cancer," Endocrine-Related Cancer, vol. 16, no. 4, pp. 1103-1123, 2009.
54. V. P. Singh, A. Bali, N. Singh, and A. S. Jaggi, "Advanced glycation end products and diabetic complications," The Korean Journal of Physiology and Pharmacology, vol. 18, no. 1, pp. 1-14, 2014.
55. T. Balasubramanian, "Therapeutic effect of stereospermum suavelolens on diabetic nephropathy," Clinical & Experimental Pharmacology, vol. 4, no. 5, article no. 162, 2014.
56. N. L. Alderson, M. E. Chachich, N. Frizzell et al., "Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat," Diabetologia, vol. 47, no. 8, pp. 1385-1395, 2004.
57. I. Abdelaziz and M. Kandeel, "The protective effects of Nigella sativa oil and Allium sativum extract on amikacin-induced nephrotoxicity," International Journal of Pharmacology, vol. 7, no. 6, pp. 697-703, 2011.
58. E. Saleh, "Antioxidant effect of aqueous extract of propolis on hepatotoxicity induced by octylphenol in male rats," Acta Toxicologica Argentina, vol. 20, no. 2, pp. 68-81, 2012.
59. O. Abo-Salem, R. H. El-Edel, G. Harisa, N. El-Halawany, and M. Ghonaim, "Experimental diabetic nephropathy can be prevented by propolis: effect on metabolic disturbances and renal oxidative parameters," Pakistan Journal of Pharmaceutical Sciences, vol. 22, no. 2, pp. 205-210, 2009.
60. M. Premalatha and C. S. Parameswari, "Renoprotective effect of chrysin (5,7 dihydro flavone) in Streptozotocin induced diabetic nephropathy in rats," International Journal of Pharmacy and Pharmaceutical Sciences, vol. 4, no. 3, pp. 241-247, 2012.
61. S. Wang, X. Hou, Y. Liu et al., "Serum electrolyte levels in relation to macrovascular complications in Chinese patients with diabetes mellitus," Cardiovascular Diabetology, vol. 12, pp. 146-155, 2013.
62. K. Al-Rubeaan, K. Siddiqui, K. Abu Risheh et al., "Correlation between serum electrolytes and fasting glucose and Hb1Ac in Saudi diabetic patients," Biological Trace Element Research, vol. 144, no. 1-3, pp. 463-468, 2011.
63. G. Liamis, E. Liberopoulos, F. Barkas, and M. Elisaf, "Diabetes mellitus and electrolyte disorders," World Journal of Clinical Cases, vol. 2, no. 10, pp. 488-496, 2014.
64. S. K. Ramudu, M. Korivi, N. Kesireddy et al., "Nephroprotective effects of a ginger extract on cytosolic andmitochondrial enzymes against streptozotocin (STZ)-induced diabetic complications in rats," Chinese Journal of Physiology, vol. 54, no. 2, pp. 79-86, 2011.
65. D. Ahmed, V. Kumar, A. Verma et al., "Antidiabetic, renal/ hepatic/pancreas/cardiac protective and antioxidant potential of methanol/dichloromethane extract of Albizzia Lebbeck Benth. stem bark (ALEx) on streptozotocin induced diabetic rats," BMC Complementary and Alternative Medicine, vol. 14, article no. 243, 2014.
66. M. Kanter, "Protective effects of thymoquinone on streptozotocin-induced diabetic nephropathy," Journal of Molecular Histology, vol. 40, no. 2, pp. 107-115, 2009.
67. M. Al-Hariri, T. A. G. Eldin, and M. Al-Harb, "Protective effect and potential mechanisms of propolis on streptozotocininduced diabetic rats," Journal of Taibah University Medical Sciences, vol. 11, no. 1, pp. 7-12, 2016.